Medspa Treatment Pricing Benchmarks (National & Regional)

Botox Cosmetic (onabotulinumtoxinA) remains the volume driver for most practices. National average pricing runs $12–$16 per unit for established practices in mid-to-large metros; boutique or high-barrier-to-entry practices in coastal markets (NYC, LA, Miami, SF) command $18–$22 per unit. Practices in secondary markets (Austin, Denver, Nashville) typically land at $10–$14 per unit. A standard glabellar/forehead/crow's feet treatment uses 20–30 units; that translates to $240–$480 nationally, with outliers at $360–$660 in premium markets. Dysport (abobotulinumtoxinA, Galderma) prices 15–20% lower per unit because it diffuses more; expect $0.10–$0.14 per unit discount. Daxxify (prabotulinumtoxinA, Revance), cleared in 2023, commands a premium—$16–$24 per unit—because it lasts 6 months instead of 3–4, but adoption remains patchy outside major metros. Jeuveau (evoltulinumtoxinA, Evolus) sits between Botox and Dysport in price, typically $11–$15 per unit. Volume and rebate programs matter enormously: Allergan's Alle platform and Aspire loyalty program offer quarterly rebates (typically 10–15% on qualifying volume thresholds); Evolus Rewards works similarly. A practice moving 500+ units per month can negotiate 5–8% better net pricing than list rates.

HA fillers price by syringe (typically 1 mL) and by product line. Restylane (Galderma) and Juvéderm (Allergan) dominate; both run $400–$700 per syringe nationally, with premium lines (Volbella, Vollure, Restylane Refyne) at the higher end. Belotero (Merz) prices slightly lower, $350–$600, because it's thinner and marketed for fine lines. RHA (Revance), a newer HA with improved elasticity, prices at $500–$750 per syringe and is gaining share in practices targeting natural movement. Regional variation is sharp: NYC and LA practices charge $600–$900 per syringe; secondary markets run $350–$500. Practices bundling multiple syringes for full-face treatment often discount 10–15% on the second and third syringe. Crosslinked HA (Juvéderm Ultra, Restylane Lyft) lasts longer and costs more—$500–$800—than non-crosslinked (Restylane Silk, Juvéderm Volbella), which run $400–$600. Filler loyalty programs are less generous than toxin programs, but Allergan's Alle and Galderma's Aspire offer modest rebates (5–8%) on volume. Cost of goods for a 1 mL syringe runs $40–$80 wholesale, so gross margin on fillers is 70–85%—higher than toxin.

Sculptra (PLLA, Galderma) and Radiesse (CaHA, Merz) occupy a middle ground: higher per-treatment cost than fillers, longer duration, and more patient education required. Sculptra prices $600–$1,000 per vial (1.5 mL reconstituted); a typical course is 2–3 vials per session, spaced 4–6 weeks apart, for a total outlay of $1,200–$3,000. Premium markets charge $800–$1,200 per vial. Radiesse runs $500–$800 per syringe; most patients need 1–2 syringes per session. Both require patient buy-in on timeline and results (gradual collagen stimulation over weeks to months). Practices with strong patient education and follow-up systems price these higher because retention and repeat treatment rates are better. Radiesse has gained traction post-weight-loss-drug era because it addresses volume loss in the face and jawline—a key complaint from GLP-1 users. Cost of goods is $80–$150 per unit, so margins are similar to premium fillers.

RF microneedling (Morpheus8, InMode; Genius, Cutera) prices per treatment session, not per unit. National average is $400–$800 per session for full-face treatment; premium markets (NYC, LA) charge $600–$1,200. A typical course is 3–4 sessions spaced 4–6 weeks apart. Device acquisition cost is high ($80K–$200K depending on platform and bundled handpieces), so per-session pricing must cover depreciation, maintenance, and operator time. Practices running 8–10 RF sessions per week break even in 18–24 months. Ultrasound (Ultherapy, Merz; Ulthera, Cutera) prices similarly, $600–$1,200 per full-face session, with similar course requirements. Fractional laser (CO2, erbium) runs $300–$600 per session in secondary markets, $500–$1,000 in premium markets. Device financing (lease vs. purchase) affects net pricing: a $150K device on a 5-year lease costs $2,500–$3,500 per month, so a practice needs to generate $10K–$15K in device revenue monthly to stay profitable. Regional variation reflects both market willingness-to-pay and practitioner density.

Coastal metros (NYC, LA, SF, Miami, Boston) command 30–50% premiums over secondary markets (Phoenix, Denver, Austin, Nashville, Charlotte). A Botox treatment that costs $300 in Denver costs $450–$500 in Manhattan. This reflects higher rent, higher staff salaries, higher patient acquisition cost, and lower price sensitivity among patients. Secondary markets are growing faster in absolute terms because they have lower competition density and higher population growth. Midwest and South markets (Chicago, Dallas, Atlanta, Houston) fall in the middle: 10–20% above secondary-market pricing, 20–30% below coastal. International pricing is fragmented: Canada runs 15–25% higher than US; UK and Australia run 20–30% higher due to VAT and import duties. Practices in high-competition secondary markets (e.g., Austin, where new practices open monthly) are under pricing pressure; expect 5–10% annual compression. Practices in low-competition secondary markets can hold or raise prices 3–5% annually.

Start with your cost of goods (toxin per unit, filler per syringe, device depreciation per session) and your overhead (rent, staff, insurance, utilities). Add your desired profit margin (40–60% is standard for aesthetic practices). Then check your local market: call 5–10 competitors, visit their websites, ask patients what they paid elsewhere. If you're in the top quartile for credentials or outcomes, price at or above market; if you're building a practice, price 10–15% below market to drive volume. Test price increases in 5–10% increments every 6–12 months; most patients don't notice or complain. Use bundling (e.g., 3 syringes for 15% off) to increase transaction size without appearing to cut price. Track your per-treatment time and revenue per hour; if you're spending 45 minutes on a $300 Botox appointment, your effective hourly rate is $400—acceptable for a nurse injector, low for a physician. Loyalty programs (Alle, Aspire, Evolus Rewards) reduce your net realization by 5–10%, so factor that into your list price. Finally, separate your pricing by provider: a physician injector commands 20–30% premium over a nurse injector for the same treatment, and patients will pay it if you market the difference.